Skip to main content

Table 4 Multivariate logistic regression analysis of factors affecting critical illness progression

From: Thymalfasin therapy accelerates COVID-19 pneumonia rehabilitation through anti-inflammatory mechanisms

 

OR

Z value

P value

Use of Thymalfasin or not

0.12

-2.019

0.04

WBC (10 as the demarcation)

3.11

1.81

0.07

CRP (50 as the demarcation)

8.08

2.66

0.0078

PCT (0.05 as the demarcation)

2.66

1.23

0.21

  1. Multivariate logistic regression indicated that the use of Thymalfasin was an independent protective factor of critical illness progression, while CRP elevation was an independent risk factor